A Look Inside AAD VMX 2021

This past weekend, the staff at Aesthetic Authority and Dermatology Times covered the American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX). Below you can find a variety of conference-related articles we published, ranging from DAXI trial updates to Zoom Dysmorphia. Click the links to read full-length stories on all of the latest news coming out of AAD VMX 2021.

Revance Presents Study Data on DAXI and HA Filler at AAD VMX

Revance presents 4 AAD VMX ePoster abstracts examining phase 3 study data for DAXI, and the impact of HA filler manufacturing technologies on HA chain degradation.

Laser Considerations for Skin of Color

Physicians must learn how to tailor treatments and assess skin of color risk to best serve the POC patient population. Doing so will deliver positive outcomes and drive patient satisfaction.

Zoom Dysmorphia Results in Increase of Cosmetic Consultations

A survey finds that patients are referencing video conferencing as the reason for seeking cosmetic consultation since the beginning of the pandemic.

Phase 2 Study of Ruxolitinib Cream for Vitiligo Announces New Findings

Incyte's Phase 2 study evaluating ruxolitinib cream for vitiligo meets primary endpoint, shows improvement in body and facial repigmentation compared to placebo.

Can Telemedicine Survive Beyond COVID-19?

Telemedicine flourished among dermatology practices in the wake of COVID-19. But as the world tentatively reopens, questions about connectivity, regulations, and payment will have to be addressed before physicians decide what role virtual visits will play in their practices.

Hair Restoration Goes High-Tech

Futuristic tools including robotics and new types of lasers are just some of the therapeutic innovations aimed at slowing hair loss and increasing hair growth.